Maelstrom Research Staging | POPCORN_COVID19_SARSCoV2_positive_Negative_control

POPCORN_COVID19_SARSCoV2_positive_Negative_control_Baseline

Networks -

Variables -

Associated study POPCORN-COVID-19 Contingency Table

Population

POPCORN-COVID-19 - SARS-CoV-2 negative - Control

The population is composed of children under 18 years of age who are pediatric ED patients or inpatient ward units with acute non-febrile or mild febrile illness, accidental injury, or outpatients requiring bloodwork for other reasons and who tested negative for SARS-CoV-2 infection by reverse transcription-polymerase chain reaction (RT-PCR) or equivalent and presenting with acute COVID-19-like symptoms.

Selection Criteria

Maximum age

Newborns

Twins

Countries

Canada

Territory

Ethnic Origin

Health Status

Participants are included if they tested for SARS-CoV-2 infection. Presented symptoms related other respiratory infectious syndromes (e.g., respiratory syncytial virus, influenza), febrile young infant < 60 days, gastrointestinal symptoms – including hepatitis, and others (e.g., neurological)).

Supplementary Information about selection criteria

Participants consented to the biobank only as a biobank control.

Recruitment

Sources of recruitment

Specific population

Specific Population

Clinic patients

Supplementary Information

* Paricipants are recruited across 16 academic pediatric institutions which are BC Children’s Hospital (Vancouver), Stollery Children’s Hospital (Edmonton), Alberta Children’s Hospital (Calgary), Jim Pattison Children’s Hospital (Saskatoon), The Children’s Hospital of Winnipeg (Winnipeg), McMaster Children’s Hospital (Hamilton), The Hospital for Sick Children (Toronto), Kingston Health Sciences Centre (Kingston), Children’s Hospital of Eastern Ontario (Ottawa), Children's Hospital London Health Sciences Centre (London), Montreal Children’s Hospital (Montreal), CHU Sainte-Justine (Montreal), CHU de Sherbrooke (Sherbrooke), CHU de Quebec l‘Université de Laval (Quebec City), Janeway Children’s Health and Rehabilitation Centre (St. John’s), and IWK Health Centre (Halifax).

Number of Participants

Number of Participants: 4,000
Number of Participants with Biological Samples

More info

Data Collection Event

POPCORN-COVID-19 - SARS-CoV-2 negative Control - Baseline

Information on demographics, height and weight, premature birth, SARS-CoV-2 infections (symptoms, history, testing, exposure) and vaccinations (dates, vaccine manufacturer, number of doses), history of other vaccinations, medications, hospital stays/visits (including the PICU, ICU, and ED), therapeutic interventions (ventilation support), pre-existing medical conditions, health equity, quality of life (Pediatric Quality of Life Inventory), and mental health (Revised Children’s Anxiety and Depression Scale) is collected. Information is also collected about prior myo/pericarditis and multisystem inflammatory syndrome events and adverse events following immunization for a subset of participants.

More info

Collected Dataset / POPCORN_COVID19_SARSCoV2_positive_Negative_control_Baseline

POPCORN_COVID19_SARSCoV2_positive_Negative_control_Baseline

Population

POPCORN-COVID-19 - SARS-CoV-2 negative - Control

Data Collection Event

POPCORN-COVID-19 - SARS-CoV-2 negative Control - Baseline

Files

Variables Classifications